Stabilised prostaglandin composition

Details for Australian Patent Application No. 2005268645 (hide)

Owner Controlled Therapeutics (Scotland) LTD

Inventors Robertson, Steven

Agent Shelston IP

Pub. Number AU-B-2005268645

PCT Pub. Number WO2006/013335

Priority 0417401.7 05.08.04 GB

Filing date 28 July 2005

Wipo publication date 9 February 2006

Acceptance publication date 25 November 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/02 (2006.01) Medicinal preparations characterised by special physical form - Suppositories

A61K 31/5575 (2006.01)

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/013335 Priority application(s): WO2006/013335

25 November 2010 Application Accepted

  Published as AU-B-2005268645

24 March 2011 Standard Patent Sealed

24 May 2012 Assignment Registered

  Controlled Therapeutics (Scotland) LTD The patent has been assigned to Ferring B.V.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005268646-HPV vaccine comprising peptides from host cell proteins

2005268644-HAI-1 and HAI-2 in cancer therapy